Sublingual alternative to shots recommended for pediatric allergies; Recipharm, Synthonics team up to deliver pharma compounds;

> Under-the-tongue oral "drops" appear to offer a viable alternative to shots as a treatment for pediatric allergy patients. Item

> Recipharm Pharmaceutical Development and Synthonics have teamed up to allow the Swedish manufacturer Recipharm to use U.S. company Synthonics' metal coordination chemistry to deliver their compounds. More

> A new gel made from a substance found in the fruit and leaves of the papaya tree delivers a powerful treatment that dissolves tooth decay, a gentler alternative than a dentist's drill. Story

> MagForce won a European patent for its nanoparticle-drug conjugate NanoTherm, which can be heated inside a tumor to release the drug in high concentration therein. The platform has regulatory approval in 27 European countries. News

> Agile Therapeutics announced positive results in two Phase III studies of the company's investigational, once-weekly low-dose contraceptive patch containing ethinyl estradiol and levonorgestrel. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.